7780.T
Menicon Co., Ltd. [7780.T] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
7780.T Stock Summary
Top 10 Correlated ETFs
7780.T
Top 10 Correlated Stocks
7780.T
In the News
7780.T Financial details
Company Rating
-
Market Cap
179.45B
Income
6.44B
Revenue
114.19B
Book val./share
-
Cash/share
-
Dividend
25
Dividend %
1.06%
Employees
4.06K
Optionable
No
Shortable
Yes
Earnings
08 Feb 2024
P/E
27.82
Forward P/E
23.97
PEG
-9.96
P/S
1.57
P/B
2.26
P/C
-
P/FCF
-
Quick Ratio
2.72
Current Ratio
3.77
Debt / Equity
0.91
LT Debt / Equity
0.87
-
-
EPS (TTM)
61.77
EPS next Y
98.46
EPS next Q
-
EPS this Y
13.45%
EPS next Y
59.39%
EPS next 5Y
101.72%
EPS last 5Y
13.87%
Revenue last 5Y
6.38%
Revenue Q/Q
4.34%
EPS Q/Q
-
-
-
-
-
SMA20
23.27%
SMA50
13.03%
SMA100
-9.27%
Inst Own
-
Inst Trans
-
ROA
4%
ROE
8%
ROC
0.07%
Gross Margin
52%
Oper. Margin
9%
Profit Margin
6%
Payout
-
Shs Outstand
76.14M
Shs Float
58.87M
-
-
-
-
Target Price
-
52W Range
1658.0-3060.0
52W High
-22.86%
52W Low
+42.37%
RSI
71.54
Rel Volume
2
Avg Volume
398.38K
Volume
796.5K
Perf Week
7.1%
Perf Month
36.41%
Perf Quarter
-6.24%
Perf Half Y
-8.68%
-
-
-
-
Beta
0.279
-
-
Volatility
119.71%, 196.04%
Prev Close
-2.46%
Price
2360.5
Change
2.9%
7780.T Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-03-31
| Metric | History | 2019-03-31 | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 1.15K | 1.17K | 1.14K | 1.32K | 1.45K | |
| Net income per share | 50.8 | 56.11 | 78.83 | 85.71 | 97.24 | |
| Operating cash flow per share | 99.78 | 120.4 | 140.77 | 168.21 | 168.05 | |
| Free cash flow per share | 25.87 | 30.89 | -16.52 | -42.68 | -2.98 | |
| Cash per share | 257.9 | 211.56 | 516.48 | 400.63 | 544.21 | |
| Book value per share | 603.89 | 738.93 | 807.03 | 886 | 983.5 | |
| Tangible book value per share | 515.89 | 642.03 | 646.04 | 733.22 | 832.99 | |
| Share holders equity per share | 603.89 | 738.93 | 807.03 | 886 | 983.5 | |
| Interest debt per share | 270.57 | 188.18 | 603.07 | 565.6 | 711.02 | |
| Market cap | 111.92B | 174.56B | 246.51B | 222.08B | 212.95B | |
| Enterprise value | 110.7B | 170.66B | 250.36B | 231.46B | 225.28B | |
| P/E ratio | 31.3 | 42.99 | 41.42 | 34.27 | 28.87 | |
| Price to sales ratio | 1.38 | 2.07 | 2.86 | 2.22 | 1.93 | |
| POCF ratio | 15.94 | 20.04 | 23.19 | 17.46 | 16.7 | |
| PFCF ratio | 61.46 | 78.1 | -197.68 | -68.82 | -942.24 | |
| P/B Ratio | 2.63 | 3.26 | 4.05 | 3.31 | 2.85 | |
| PTB ratio | 2.63 | 3.26 | 4.05 | 3.31 | 2.85 | |
| EV to sales | 1.37 | 2.02 | 2.9 | 2.31 | 2.04 | |
| Enterprise value over EBITDA | 10.58 | 14.03 | 17.14 | 13.14 | 11.54 | |
| EV to operating cash flow | 15.76 | 19.59 | 23.56 | 18.2 | 17.67 | |
| EV to free cash flow | 60.79 | 76.36 | -200.77 | -71.73 | -996.8 | |
| Earnings yield | 0.03 | 0.02 | 0.02 | 0.03 | 0.03 | |
| Free cash flow yield | 0.02 | 0.01 | -0.01 | -0.01 | 0 | |
| Debt to equity | 0.44 | 0.25 | 0.74 | 0.63 | 0.72 | |
| Debt to assets | 0.24 | 0.15 | 0.36 | 0.32 | 0.35 | |
| Net debt to EBITDA | -0.12 | -0.32 | 0.26 | 0.53 | 0.63 | |
| Current ratio | 2.29 | 1.92 | 3.12 | 2.83 | 3.19 | |
| Interest coverage | 32.02 | 37.41 | 35.4 | 29.99 | 33.41 | |
| Income quality | 1.23 | 1.39 | 1.27 | 1.28 | 1.11 | |
| Dividend Yield | 0.01 | 0.01 | 0 | 0.01 | 0.01 | |
| Payout ratio | 0.25 | 0.24 | 0.18 | 0.2 | 0.21 | |
| Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
| Research and developement to revenue | 0.05 | 0.05 | 0.04 | 0.04 | 0.04 | |
| Intangibles to total assets | 0.08 | 0.08 | 0.1 | 0.09 | 0.08 | |
| Capex to operating cash flow | -0.74 | -0.74 | -1.12 | -1.25 | -1.02 | |
| Capex to revenue | -0.06 | -0.08 | -0.14 | -0.16 | -0.12 | |
| Capex to depreciation | -1.12 | -1.19 | -1.97 | -2.19 | -1.74 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 830.84 | 965.87 | 1.2K | 1.31K | 1.47K | |
| ROIC | 0.06 | 0.06 | 0.05 | 0.06 | 0.06 | |
| Return on tangible assets | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | |
| Graham Net | -70.36 | -64.88 | -145.08 | -228.79 | -244.62 | |
| Working capital | 24.02B | 19.97B | 47.68B | 41.5B | 53.35B | |
| Tangible asset value | 36.31B | 46.46B | 48.78B | 55.44B | 63.19B | |
| Net current asset value | 6.86B | 7.96B | 4.46B | 252M | -158M | |
| Invested capital | 0.44 | 0.25 | 0.74 | 0.63 | 0.72 | |
| Average receivables | 8.94B | 9.3B | 10.23B | 11B | 11.84B | |
| Average payables | 4.36B | 4.42B | 4.29B | 4.55B | 5.25B | |
| Average inventory | 11.68B | 12.44B | 14.21B | 15.64B | 16.6B | |
| Days sales outstanding | 39.96 | 42.03 | 45.45 | 41.06 | 41.11 | |
| Days payables outstanding | 42.8 | 40.62 | 38 | 37.77 | 39.58 | |
| Days of inventory on hand | 114.46 | 120.11 | 140.06 | 121.81 | 122.92 | |
| Receivables turnover | 9.13 | 8.68 | 8.03 | 8.89 | 8.88 | |
| Payables turnover | 8.53 | 8.98 | 9.61 | 9.66 | 9.22 | |
| Inventory turnover | 3.19 | 3.04 | 2.61 | 3 | 2.97 | |
| ROE | 0.08 | 0.08 | 0.1 | 0.1 | 0.1 | |
| Capex per share | -73.91 | -89.52 | -157.28 | -210.89 | -171.03 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q2
| Metric | History | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 359.79 | 373.44 | 365.16 | 374.26 | 0 | |
| Net income per share | 28.24 | 34.2 | 6.83 | 20.75 | 0 | |
| Operating cash flow per share | 0 | 0 | 0 | 0 | 0 | |
| Free cash flow per share | 0 | 0 | 0 | 0 | 0 | |
| Cash per share | 567.11 | 554.17 | 543.64 | 682.02 | 0 | |
| Book value per share | 946.52 | 974.37 | 982.48 | 1K | 0 | |
| Tangible book value per share | 793.06 | 824.37 | 832.13 | 854.9 | 0 | |
| Share holders equity per share | 946.52 | 974.37 | 982.48 | 1K | 0 | |
| Interest debt per share | 736.68 | 718.88 | 706.68 | 956.19 | 0 | |
| Market cap | 225.46B | 210.77B | 213.17B | 190.66B | 0 | |
| Enterprise value | 238.25B | 223.2B | 225.5B | 211.39B | 22.37B | |
| P/E ratio | 26.31 | 20.31 | 102.68 | 30.23 | 0 | |
| Price to sales ratio | 8.26 | 7.44 | 7.69 | 6.7 | 0 | |
| POCF ratio | 0 | 0 | 0 | 0 | 0 | |
| PFCF ratio | 0 | 0 | 0 | 0 | 0 | |
| P/B Ratio | 3.14 | 2.85 | 2.86 | 2.5 | 0 | |
| PTB ratio | 3.14 | 2.85 | 2.86 | 2.5 | 0 | |
| EV to sales | 8.73 | 7.88 | 8.13 | 7.43 | 0.75 | |
| Enterprise value over EBITDA | 70.4 | 57.14 | 162.7 | 83.82 | 8.27 | |
| EV to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
| EV to free cash flow | 0 | 0 | 0 | 0 | 0 | |
| Earnings yield | 0.01 | 0.01 | 0 | 0.01 | 0 | |
| Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
| Debt to equity | 0.78 | 0.74 | 0.72 | 0.95 | 0.91 | |
| Debt to assets | 0.37 | 0.36 | 0.35 | 0.42 | 0.41 | |
| Net debt to EBITDA | 3.78 | 3.18 | 8.9 | 8.22 | 8.27 | |
| Current ratio | 3.38 | 3.41 | 3.19 | 3.93 | 3.77 | |
| Interest coverage | 37.01 | 39.95 | 16.98 | 20.13 | 18.31 | |
| Income quality | 0 | 0 | 0 | 0 | 0 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0.08 | 0.08 | 0.08 | 0.07 | 0.06 | |
| Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
| Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
| Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 775.58 | 865.92 | 388.69 | 684.51 | 0 | |
| ROIC | 0.02 | 0.02 | 0 | 0.01 | 0.01 | |
| Return on tangible assets | 0.02 | 0.02 | 0 | 0.01 | 0.01 | |
| Graham Net | -230.45 | -213.59 | -244.36 | -331.2 | 0 | |
| Working capital | 53.69B | 54.48B | 53.35B | 66.31B | 64.58B | |
| Tangible asset value | 60.14B | 62.55B | 63.19B | 64.98B | 68.2B | |
| Net current asset value | -1.49B | 519M | -158M | -6.59B | -8.09B | |
| Invested capital | 0.78 | 0.74 | 0.72 | 0.95 | 0.91 | |
| Average receivables | 11.82B | 12.48B | 12.72B | 12.47B | 13.02B | |
| Average payables | 5.29B | 5.56B | 5.68B | 5.76B | 6B | |
| Average inventory | 16.24B | 16.81B | 17.21B | 17.83B | 18.36B | |
| Days sales outstanding | 39.33 | 41.39 | 40.28 | 39.67 | 40.95 | |
| Days payables outstanding | 38.44 | 39.25 | 37.04 | 39.81 | 38.27 | |
| Days of inventory on hand | 118.98 | 116.03 | 115.02 | 122.79 | 116.23 | |
| Receivables turnover | 2.29 | 2.17 | 2.23 | 2.27 | 2.2 | |
| Payables turnover | 2.34 | 2.29 | 2.43 | 2.26 | 2.35 | |
| Inventory turnover | 0.76 | 0.78 | 0.78 | 0.73 | 0.77 | |
| ROE | 0.03 | 0.04 | 0.01 | 0.02 | 0.02 | |
| Capex per share | 0 | 0 | 0 | 0 | 0 |
7780.T Frequently Asked Questions
What is Menicon Co., Ltd. stock symbol ?
Menicon Co., Ltd. is a JP stock and trading under the symbol 7780.T
What is Menicon Co., Ltd. stock quote today ?
Menicon Co., Ltd. stock price is $2360.5 today.
Is Menicon Co., Ltd. stock public?
Yes, Menicon Co., Ltd. is a publicly traded company.
Company Profile
- Volume Average 398.38K
- Market Capitalization 179.45B
- Employee 4.06K
- CEO Dr. Hidenari Tanaka
- Headquarters Nagoya,JP
- IPO Date 2015-06-25
-
Website
https://www.menicon.co.jp 
Menicon Co., Ltd. manufactures and sells contact lenses and lens care products. The company offers its products to hospitals, ophthalmology clinics, contact lens stores, eyeglass stores, and drug stores. It exports its products in 80 countries, including the United States, Europe, Oceania, and Asia. Menicon Co., Ltd. was incorporated in 1943 and is headquartered in Nagoya, Japan.
